References
1. Laurence J. A cure for AIDS? AIDS Reader. 2007;17:338-339.
2. Chun TW, Justement JS, Moir S, et al. Decay of the HIV reservoir in patients receiving antiretroviral therapy for extended periods: implications for eradication of virus. J Infect Dis. 2007;195:1762-1764.
3. Margolis DM, Archin NM. Eliminating persistent HIV infection: getting to the end of the rainbow. J Infect Dis. 2007;195:1734-1736.
4. Palmer S, Maldarelli F, Wiegand A, et al. Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy. Proc Natl Acad Sci U S A. 2008;105:3879-3884.
5. Hutter G, Nowak D, Mossner M, et al. Treatment of HIV-1 infection by allogeneic CCR5-Δ32/Δ32 stem cell transplantation: a promising approach. 15th Conference on Retroviruses and Opportunistic Infections; February 3-6, 2008; Boston. Abstract 719.
6. Libert F, Cochaux P, Beckman G, et al. The ΔCCR5 mutation conferring protection against HIV-1 in Caucasian populations has a single and recent origin in Northeastern Europe. Hum Mol Genet. 1998;7:399-406.
7. Lukashov V, Quinones-Mateu M, McGarrity G, et al. Lentiviral delivered VRX496 long antisense sequences exerts molecular pressure on HIV-1 in human subjects. 15th Conference on Retroviruses and Opportunistic Infections; February 3-6, 2008; Boston. Abstract 753a.
8. Evans D. Transplanting hope: stem cell experiment raises eyebrows at CROI. POZ. March 11, 2008.
